Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chapel Hill, North Carolina 27514


Purpose:

The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children.


Criteria:

Inclusion Criteria: - Anyone aged 5-10 years with the clinical diagnosis of molluscum contagiosum. Exclusion Criteria: - Anyone with immunosuppression including HIV or previous organ transplantation. - Anyone taking immunosuppressive medications. - Anyone who has previously received treatment with cantharidin. - Any female who has had her first menstrual period.


NCT ID:

NCT00667225


Primary Contact:

Principal Investigator
Jacquelyn R Dosal, MD
UNC


Backup Contact:

N/A


Location Contact:

Chapel Hill, North Carolina 27514
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.